Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Aikido Pharma Inc (AIKI)

Aikido Pharma Inc (AIKI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 21,502
  • Shares Outstanding, K 5,485
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,170 K
  • 60-Month Beta 1.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.26
Trade AIKI with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -1.11
  • Number of Estimates 1
  • High Estimate -1.11
  • Low Estimate -1.11
  • Prior Year -0.34
  • Growth Rate Est. (year over year) -226.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.81 +2.25%
on 11/25/22
6.44 -39.44%
on 10/27/22
-2.31 (-37.20%)
since 10/25/22
3-Month
3.81 +2.25%
on 11/25/22
7.27 -46.34%
on 10/05/22
-2.39 (-38.00%)
since 08/25/22
52-Week
3.81 +2.25%
on 11/25/22
12.92 -69.81%
on 12/01/21
-8.97 (-69.70%)
since 11/24/21

Most Recent Stories

More News
AIkido Share Repurchase Continues

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today provided an update on the Company's share repurchase program (the "Share...

AIKI : 3.90 (-0.51%)
Dominari Financial, Inc. Executes Definitive Agreement to Buy Broker-Dealer

/PRNewswire/ -- Dominari Financial, Inc., the financial services subsidiary of AIkido Pharma Inc., (NASDAQ: AIKI) has entered into an exclusive agreement for...

AIKI : 3.90 (-0.51%)
AIkido Pharma, Inc. Hires Carlos Aldavero to Lead Financial Services Subsidiary

/PRNewswire/ -- Anthony Hayes, CEO of AIkido Pharma Inc. (NASDAQ: AIKI) ("AIkido" or the "Company"), announced the hiring of Carlos Aldavero as President of...

AIKI : 3.90 (-0.51%)
AIkido Inc. Announces the Formation of a New Financial Services Subsidiary

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") announced the formation of a wholly owned subsidiary with the purpose of making...

AIKI : 3.90 (-0.51%)
AIkido Pharma Inc. Appoints New Director, Soo Yu

/PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido" or the "Company") today announced the appointment of Ms. Soo Yu, as a director of the Company....

AIKI : 3.90 (-0.51%)
Psychedelics Companies are Establishing Core IPs in Growing Market

FN Media Group Presents Microsmallcap.com Market Commentary

PULL.CN : 0.010 (unch)
PRXTF : 0.0110 (+12.24%)
FTRP.CN : 5.550 (+1.46%)
FTRPF : 5.7460 (-2.32%)
AIKI : 3.90 (-0.51%)
RVV.CN : 0.175 (-5.41%)
RVVTF : 0.1300 (-1.89%)
CBDT.CN : 0.050 (unch)
EPWCF : 0.0550 (+19.31%)
Why Canada is Becoming a Hub for Psychedelics Research and Development

FN Media Group Presents Microsmallcap.com Market Commentary

NUMI.VN : 0.580 (+9.43%)
LKYSF : 0.4800 (-3.63%)
CBDT.CN : 0.050 (unch)
EPWCF : 0.0550 (+19.31%)
RVV.CN : 0.175 (-5.41%)
RVVTF : 0.1300 (-1.89%)
LITT.VN : 0.080 (+14.29%)
RMANF : 0.0400 (+9.89%)
AIKI : 3.90 (-0.51%)
First Movers in the Psychedelics Space Position Themselves as Industry Leaders

FN Media Group Presents Microsmallcap.com Market Commentary

PULL.CN : 0.010 (unch)
PRXTF : 0.0110 (+12.24%)
RVV.CN : 0.175 (-5.41%)
RVVTF : 0.1300 (-1.89%)
MYCO.CN : 0.400 (-6.98%)
MYCOF : 0.4400 (-4.35%)
AIKI : 3.90 (-0.51%)
CMPS : 10.05 (-4.10%)
Psilocybin Extracts Could Be the Key to Unlocking Psychedelic Health and Wellness

FN Media Group Presents Microsmallcap.com Market Commentary

PULL.CN : 0.010 (unch)
PRXTF : 0.0110 (+12.24%)
CMPS : 10.05 (-4.10%)
CYBN : 0.4300 (unch)
CLXPF : 3.0200 (-1.31%)
AIKI : 3.90 (-0.51%)
NUMI.VN : 0.580 (+9.43%)
LKYSF : 0.4800 (-3.63%)
Silo Pharma Provides Details of Patent License Agreement for Psilocybin and Cancer Applications

Silo Pharma to Receive Upfront Payment Combination of Cash and Preferred Stock Totaling One Million Dollars

UCUT : 0.3500 (-22.22%)
SILO : 3.64 (+5.20%)
AIKI : 3.90 (-0.51%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

AIkido Pharma Inc. is a biotechnology development company with a diverse portfolio of early stage small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia and acute lymphoblastic leukemia. AIkido Pharma Inc., formerly...

See More

Key Turning Points

3rd Resistance Point 4.16
2nd Resistance Point 4.08
1st Resistance Point 3.99
Last Price 3.90
1st Support Level 3.81
2nd Support Level 3.73
3rd Support Level 3.64

See More

52-Week High 12.92
Fibonacci 61.8% 9.44
Fibonacci 50% 8.37
Fibonacci 38.2% 7.29
Last Price 3.90
52-Week Low 3.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar